Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2007-7753

2. Registrant Information.

Registrant Reference Number: PROSAR Case 1-15129265

Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation

Address: 400 Plaza Drive

City: Secaucus

Prov / State: New Jersey

Country: USA

Postal Code: 07094-3688

3. Select the appropriate subform(s) for the incident.

Domestic Animal

4. Date registrant was first informed of the incident.

20-JUL-07

5. Location of incident.

Country: CANADA

Prov / State: BRITISH COLUMBIA

6. Date incident was first observed.

20-JUL-07

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

Active(s)

PMRA Registration No. 25922      PMRA Submission No.       EPA Registration No.

Product Name: HARTZ ONCE-A-MONTH FLEA & TICK TREATMENT FOR DOGS & PUPPIES OVER 14KG

  • Active Ingredient(s)
    • PERMETHRIN

7. b) Type of formulation.

Application Information

8. Product was applied?

Yes

9. Application Rate.

Unknown

10. Site pesticide was applied to (select all that apply).

Site: Animal / Usage sur un animal domestique

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

No

Subform III: Domestic Animal Incident Report

1. Source of Report

Animal's Owner

2. Type of animal affected

Cat / Chat

3. Breed

Domestic Longhair

4. Number of animals affected

1

5. Sex

Female

6. Age (provide a range if necessary )

0.83

7. Weight (provide a range if necessary )

6.5

lbs

8. Route(s) of exposure

Skin

9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

>8 hrs <=24 hrs / > 8 h < = 24 h

11. List all symptoms

System

  • Nervous and Muscular Systems
    • Symptom - Seizure
    • Symptom - Ataxia
    • Symptom - Muscle tremors
  • Eye
    • Symptom - Nystagmus
  • Nervous and Muscular Systems
    • Symptom - Difficulty walking
  • General
    • Symptom - Fever
  • Nervous and Muscular Systems
    • Symptom - Fasciculations

12. How long did the symptoms last?

Unknown / Inconnu

13. Was medical treatment provided? Provide details in question 17.

Unknown

14. a) Was the animal hospitalized?

Unknown

14. b) How long was the animal hospitalized?

15. Outcome of the incident

Not recovered / Non rétabli

16. How was the animal exposed?

Treatment / Traitement

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

History: Caller's wife applied the product to their kitten "Ziggy" a 10 mo 6-7# DMH. Caller has noticed in the last few hours the kitten is "acting weird." She is having difficulty walking, facial and eyes twitching, body tremors and feels warm to the touch. Caller wiped off the area where the liquid was applied with water. NOTE: While on the phone with the caller, the kitten was just starting to have a seizure. Assessment: Discussed with the caller the AI is permethrin 45% which is a synthetic pyrethroid which some animals may be sensitive to. Some symptoms seen may be dermal irritation such as redness, rash, itching or parathesia type symptoms. Cats/kittens have a tendency to be very sensitive to this ingredient at this percent and may see CNS symptoms such as: Ataxia, tremors, hyperthermia or seizures. Recommend to take the kitten to your Vet ASAP for treatment Rec. to caller to have the cat treated for pyrethroid toxicity by your Vet ASAP. There is not antidote for the product, but usually recommend to use muscle relaxers, antihistamines, fluids and supportive care. Encourage the DVM to monitor the cat for a minimum of 48-72 hours. Even though the initial therapy may have been effective, clinical signs can develop for up to 72 hours - and may re-emerge after therapy is discontinued.


To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification

Major

19. Provide supplemental information here